Form 4: ResMed Director Karen Drexler Sells 425 Shares of Common Stock
SEC Form 4 Filing
Director Karen Drexler sold 425 shares of ResMed Inc. common stock at a price of $214.92 on April 29, 2024.
Summary
- On April 29, 2024, Karen Drexler, a director of ResMed Inc., sold 425 shares of ResMed Common Stock.
- The sale price was $214.92 per share.
- Following the transaction, Ms. Drexler directly owns 8,446 shares of ResMed Common Stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock sale by a company director, which is neutral in sentiment.
Industry Context
This Form 4 filing is a routine disclosure of a transaction by a company insider and doesn't necessarily indicate a broader trend within the medical device industry.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder confidence, but is unlikely to be significant given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 04/29/2024 | Date of transaction: Karen Drexler sold 425 shares of ResMed Common Stock. |
| 04/30/2024 | Signature date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.